IMG 021
Alternative Names: IMG-021Latest Information Update: 07 Mar 2021
At a glance
- Originator Unknown
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 17 Feb 2021 Discontinued - Phase-I for Unspecified (unspecified route) (Inmagene pipeline, February 2021)